Oncotelic Therapeutics, Inc. (OTC:OTLC)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Keeps a healthy share of every dollar it sells.
- Revenue
- $250K
- Net income
- $247.5M
- Net margin
- 98998.0%
Little or no net debt.
- Total debt
- $13.9M
- Cash
- $186K
- Net debt / EBITDA
- 0.04x
Owes more within a year than it holds to pay it.
- Current assets
- $1.5M
- Current liabilities
- $17.9M
- Current ratio
- 0.08
Consumes cash and must keep raising it.
- Operating cash flow
- -$1.5M
- Free cash flow
- -$1.5M
- FCF margin
- -609.8%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 447.4M
- Share growth (1y)
- 9.6%
- Cash runway
- 1 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
OTLC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 250.00 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 250.00 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.09 M | 1.85 M | 2.53 M | 490.55 K | 65.67 K | 100.80 K |
| R&D Expense | 345.00 | 795.00 | 3.34 K | 426.00 | 297.00 | 297.00 |
| Operating Expenses | 1.09 M | 1.85 M | 2.53 M | 490.97 K | 65.97 K | 101.10 K |
| Operating Income | -843.57 K | -1.85 M | -2.53 M | -490.97 K | -65.97 K | -101.10 K |
| Pretax Income | 341.01 K | -2.24 M | 361.84 M | -1.11 M | 210.45 K | -364.26 K |
| Tax Provision | 0.00 | 0.00 | 111.55 M | 0.00 | 0.00 | 0.00 |
| Net Income | 388.15 K | -2.19 M | 250.35 M | -1.05 M | 277.86 K | -298.72 K |
| EPS (Basic) | 0.00 | -0.00 | 0.59 | -0.00 | 0.00 | -0.00 |
| EPS (Diluted) | 0.00 | -0.00 | 0.59 | -0.00 | 0.00 | -0.00 |
| Shares Outstanding | 447.39 M | 443.80 M | 421.05 M | 426.44 M | 408.29 M | 407.42 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.